[1]CurrentPatentAssignee:KYMERATHERAPEUTICSINC-WO2022/125804,2022,A1Locationinpatent:Paragraph00723;00746;00747
[2]CurrentPatentAssignee:KYMERATHERAPEUTICSINC-WO2022/125804,2022,A1Locationinpatent:Paragraph00723;00746;00747
97004-04-1
1257535-53-7
201937-23-7
205744-14-5
18368-64-4
6271-78-9
1704066-72-7 | (3-(N-MethoxysulfaMoyl)phenyl)boronic acid | AA00AR6R | MFCD28400254
151889-83-7 | 7-Hydroxy-4-(hydroxymethyl)-2h-chromen-2-one | AA00ARVP | MFCD12137952
1693758-51-8 | IPI-549 | AA00ASAK | MFCD30533720
190508-50-0 | AT 1015 | AA00ASUK | MFCD11040941
182210-74-8 | (S)-5-Hydroxy-DPAT hydrobromide | AA00ATB9 | MFCD10565884
170726-98-4 | 3-Fluoro-4-methylbenzamide | AA00AUBL | MFCD01631412
167404-38-8 | 4-(2-bromoethoxy)benzene-1-sulfonylchloride | AA00AWXM | MFCD09741235
154365-37-4 | Ethyl 2-methyl-6-nitro-3-oxo-3,4-dihydro-2h-1,4-benzoxazine-2-carboxylate | AA00AZKG | MFCD08443979
16353-07-4 | 6-Propylpyrimidin-4(1H)-one | AA00B2PM | MFCD12032876
15460-12-5 | 2,4-Dibromo-6-tert-butylphenol | AA00B4TI | MFCD00463268